Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
"DIABESITY" Novel molecular drug targets for obesity and type 2 diabetes.
Leng, Gareth
(Principal Investigator)
Deanery of Biomedical Sciences
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/01/04
→
31/12/08
Funding
EU government bodies:
£426,768.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
White Adipose Tissue
Immunology and Microbiology
100%
Body Weight Gain
Immunology and Microbiology
100%
Glucocorticoid
Immunology and Microbiology
100%
Weight
Biochemistry, Genetics and Molecular Biology
100%
Hydroxysteroid Dehydrogenase
Biochemistry, Genetics and Molecular Biology
100%
Adipose Tissue
Immunology and Microbiology
30%
Insulin
Neuroscience
30%
Sprague Dawley Rat
Immunology and Microbiology
20%
Research output
Research output per year
2012
2012
2012
1
Article
Research output per year
Research output per year
Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue
Veyrat-Durebex, C.
,
Deblon, N.
,
Caillon, A.
,
Andrew, R.
,
Altirriba, J.
,
Odermatt, A.
&
Rohner-Jeanrenaud, F.
,
2012
,
In:
PLoS ONE.
7
,
3
,
p. e34002
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Glucocorticoid
100%
White Adipose Tissue
100%
Body Weight Gain
100%
Hydroxysteroid Dehydrogenase
100%
Weight
100%